Related Experiment Videos
Modulation of B cell stimulation by maternal serum
Y E Vanderbeeken1, J Duchateau, M Gregoire
1Institut Armand Frappier, Laval des Rapides, Quebec, Canada.
Immunological Investigations
|June 1, 1991
Summary
Maternal serum inhibits B cell priming and alters immunoglobulin secretion, with effects amplified by retroplacental IgG. These findings suggest a fetomaternal interface factor influences B cell responses.
Area of Science:
- Immunology
- Cell Biology
- Maternal-Fetal Medicine
Background:
- Maternal factors can influence fetal immune development.
- B cell responses are crucial for adaptive immunity.
Purpose of the Study:
- To investigate the impact of maternal serum on B cell function.
- To identify specific immunoglobulin changes and B cell surface marker alterations induced by maternal serum.
Main Methods:
- B cell stimulation with anti-IgM in the presence of maternal serum or control media.
- Analysis of B cell proliferation, immunoglobulin secretion (IgM, IgG, IgA, IgE), and CD23 antigen expression.
- Comparison of effects using peripheral and retroplacental maternal IgG.
Main Results:
- Maternal serum significantly decreased B cell priming but did not affect proliferation.
- Immunoglobulin secretion was altered: decreased IgM, unchanged IgG, and increased IgA and IgE.
- Maternal IgG, particularly retroplacental IgG, enhanced CD23 antigen expression on B cells.
Conclusions:
- Maternal serum modulates B cell responses, affecting priming and immunoglobulin profiles.
- A factor within maternal IgG, likely released at the fetomaternal interface, drives these B cell alterations.
- These findings highlight the role of the fetomaternal interface in shaping neonatal immunity.